TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03255252

Assessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapy

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“insufficient recruitment”

The sponsor’s own words in the registry.

Life of this trial

20172018201920202021202220232024Started2017-07-15Registered2017-08-10Primary completion2022-06-16Stopped2023-11-23

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Sponsor type
University, hospital or other
Conditions
Cervical Cancer
Interventions
Cisplatin injection; radiotherapy
Participants
29
Sites
3
Countries
France

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.